Inventor · disambiguated record
Swaroop K. Vakkalanka
Also filed as: VAKKALANKA SWAROOP K · VAKKALANKA SWAROOP K V S · VAKKALANKA SWAROOP KUMAR V S · VAKKALANKA SWAROOP KUMAR VENKATA SAT
56 granted patents·20 pending applications·201 citations·filing 2010–2023
98Inventor score
Files withRHIZEN PHARMACEUTICALS SA55INCOZEN THERAPEUTICS PVT LTD8RHIZEN PHARMACEUTICALS AG6MUTHUPPALANIAPPAN MEYYAPPAN5NAGARATHNAM DHANAPALAN2
Top patents by PatentIndex Score
76 records- 0197US9150579B2Selective PI3K delta inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2013·Granted Oct 6, 2015·34 cites·14 claims
- 0296US9475818B2Selective PI3K delta inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Oct 25, 2016·17 cites·20 claims
- 0395US9649302B2Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast N-oxideINCOZEN THERAPEUTICS PVT LTD·Filed 2014·Granted May 16, 2017·29 cites·16 claims
- 0494US10072013B2Selective PI3K delta inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Sep 11, 2018·9 cites·20 claims
- 0594US9669033B2Selective PI3K delta inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2016·Granted Jun 6, 2017·10 cites·15 claims
- 0693US8921364B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2012·Granted Dec 30, 2014·7 cites·23 claims
- 0793US8642607B24H-chromen-4-one compounds as modulators of protein kinasesMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2011·Granted Feb 4, 2014·17 cites·23 claims
- 0892US8912331B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2013·Granted Dec 16, 2014·17 cites·28 claims
- 0992US8377970B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2010·Granted Feb 19, 2013·7 cites·28 claims
- 1089US9018375B2Substituted chromenes as kinase modulatorsRHIZEN PHARMACEUTICALS SA·Filed 2013·Granted Apr 28, 2015·8 cites·5 claims
- 1188US10414773B2Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulationsRHIZEN PHARMACEUTICALS SA·Filed 2018·Granted Sep 17, 2019·1 cites·28 claims
- 1287US9969740B2Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulationsRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted May 15, 2018·2 cites·29 claims
- 1386US8481739B23,5-Disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H[1,2,3]triazolo [4,5-b] Pyridine Compounds as Modulators of protein kinasesMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2011·Granted Jul 9, 2013·7 cites·47 claims
- 1485US10981919B2Selective PI3K delta inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2020·Granted Apr 20, 2021·1 cites·13 claims
- 1585US10570142B2Selective PI3K delta inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2018·Granted Feb 25, 2020·2 cites·29 claims
- 1685US9421209B2Kinase modulatorsRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Aug 23, 2016·3 cites·13 claims
- 1784US10087182B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2017·Granted Oct 2, 2018·3 cites·9 claims
- 1883US9815831B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2013·Granted Nov 14, 2017·5 cites·32 claims
- 1983US9737521B2Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitorRHIZEN PHARMACEUTICALS SA·Filed 2013·Granted Aug 22, 2017·4 cites·21 claims
- 2081US10220035B2Compounds as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Mar 5, 2019·2 cites·12 claims
- 2181US2024360095A1Novel kinase modulatorsRHIZEN PHARMACEUTICALS AG·Filed 2023·Application pending·0 cites
- 2280US9783533B2Glutaminase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Oct 10, 2017·4 cites·13 claims
- 2380US9758514B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2014·Granted Sep 12, 2017·1 cites·47 claims
- 2480US8993612B2Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancerMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2010·Granted Mar 31, 2015·6 cites·14 claims
- 2578US11858907B2Kinase modulatorsRHIZEN PHARMACEUTICALS SA·Filed 2019·Granted Jan 2, 2024·0 cites·18 claims
- 2676US2021403475A1Novel selective pi3k delta inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 2775US9775841B2Compounds as modulators of protein kinasesNAGARATHNAM DHANAPALAN·Filed 2012·Granted Oct 3, 2017·2 cites·6 claims
- 2874US2021401840A1Novel compounds as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 2971US9777018B2Compounds as modulators of GPR-119RHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Oct 3, 2017·1 cites·36 claims
- 3070US11466006B2Dual selective PI3 delta and gamma kinase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2020·Granted Oct 11, 2022·0 cites·10 claims
- 3170US11020399B2Intermediates useful in the synthesis of compounds as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2019·Granted Jun 1, 2021·0 cites·2 claims
- 3270US9758474B2Immunomodulator and anti-inflammatory compoundsRHIZEN PHARMACEUTICALS SA·Filed 2014·Granted Sep 12, 2017·1 cites·8 claims
- 3369US10947244B2Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulationsRHIZEN PHARMACEUTICALS SA·Filed 2019·Granted Mar 16, 2021·0 cites·40 claims
- 3469US10668051B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2019·Granted Jun 2, 2020·0 cites·20 claims
- 3569US10246450B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2018·Granted Apr 2, 2019·0 cites·19 claims
- 3669US8686048B2Immunomodulator and anti-inflammatory compoundsMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2011·Granted Apr 1, 2014·1 cites·7 claims
- 3769US2021269446A1Forms of a pi3k delta selective inhibitor for use in pharmaceutical formulationsRHIZEN PHARMACEUTICALS SA·Filed 2020·Application pending·0 cites
- 3869US2022008400A1Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxideINCOZEN THERAPEUTICS PVT LTD·Filed 2021·Application pending·0 cites
- 3968US2021371416A1Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5- disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of c-met protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 4067US11103488B2Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast N-oxideINCOZEN THERAPEUTICS PVT LTD·Filed 2017·Granted Aug 31, 2021·0 cites·25 claims
- 4167US11065236B2Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitorRHIZEN PHARMACEUTICALS SA·Filed 2019·Granted Jul 20, 2021·0 cites·13 claims
- 4267US9944631B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Apr 17, 2018·0 cites·15 claims
- 4366US2020199133A1Selective dual inhibitors of pi3 delta and gamma protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2020·Application pending·0 cites
- 4465US2025241923A1A dual selective pi3k delta and gamma inhibitors and/or a salt-inducible kinase 3 inhibitor for treating solid tumorsINCOZEN THERAPEUTICS PVT LTD·Filed 2023·Application pending·0 cites
- 4564US10590129B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2018·Granted Mar 17, 2020·0 cites·9 claims
- 4664US10413532B2Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitorRHIZEN PHARMACEUTICALS SA·Filed 2018·Granted Sep 17, 2019·0 cites·14 claims
- 4764US2015133449A1Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5-disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2014·Application pending·0 cites
- 4864US2021032236A1Novel glutaminase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2020·Application pending·0 cites
- 4963US10538501B2Kinase modulatorsRHIZEN PHARMACEUTICALS SA·Filed 2016·Granted Jan 21, 2020·0 cites·22 claims
- 5063US10058539B2Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitorRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Aug 28, 2018·0 cites·33 claims
Showing the top 50 of 76 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →